Retro Biosciences

The AI engine Fit Assessment

Beta

Retro Biosciences is focused on developing therapeutics that target the cellular mechanisms of aging, including cellular reprogramming and autophagy. Their mission is to enhance healthy human lifespan by addressing age-related diseases through innovative research and development.

Blurb

Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics.

HQ Location

Redwood City (United States)

Founded

2021

Employees

51 - 200

Total funding raised

$180.00M

Last Funding Event

Pre-Seed, $180.00M, April 6, 2022

Smart insights

  • 6m headcount growth: 1%
  • 1Y headcount growth: 8%
  • Headcount-to-last-round ratio: 0.4 employees/$M

Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics. The company is engaged in cellular reprogramming, autophagy, and developing therapeutics inspired by plasma to combat aging. Retro Biosciences aims to extend healthy human lifespan by 10 years through innovative biotechnology focused on aging.